| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| María Florencia Iveli, Alejandro Rebolledo, Pedro Martín, Nicolás Enrique, Ana Rocío Roldán Palomo, Laura Rimorini, Silvia Salemme, Verónica Miles. Risperidone inhibits contractions induced by serotonin and histamine and reduces K+ currents in smooth muscle of human umbilical artery. Reproductive sciences (Thousand Oaks, Calif.). vol 17. issue 9. 2010-11-22. PMID:20601536. |
risperidone inhibits contractions induced by serotonin and histamine and reduces k+ currents in smooth muscle of human umbilical artery. |
2010-11-22 |
2023-08-12 |
human |
| María Florencia Iveli, Alejandro Rebolledo, Pedro Martín, Nicolás Enrique, Ana Rocío Roldán Palomo, Laura Rimorini, Silvia Salemme, Verónica Miles. Risperidone inhibits contractions induced by serotonin and histamine and reduces K+ currents in smooth muscle of human umbilical artery. Reproductive sciences (Thousand Oaks, Calif.). vol 17. issue 9. 2010-11-22. PMID:20601536. |
risperidone preincubation (1-300 nmol/l for 20 minutes) produced a significant decrease in maximum force development induced by serotonin or histamine in hua rings. |
2010-11-22 |
2023-08-12 |
human |
| María Florencia Iveli, Alejandro Rebolledo, Pedro Martín, Nicolás Enrique, Ana Rocío Roldán Palomo, Laura Rimorini, Silvia Salemme, Verónica Miles. Risperidone inhibits contractions induced by serotonin and histamine and reduces K+ currents in smooth muscle of human umbilical artery. Reproductive sciences (Thousand Oaks, Calif.). vol 17. issue 9. 2010-11-22. PMID:20601536. |
when applied on top of stable contractions induced by these agonists risperidone produced quick relaxations (ic(50) = 1 nmol/l for serotonin and 72 nmol/l for histamine). |
2010-11-22 |
2023-08-12 |
human |
| Takashi Futamura, Satoshi Akiyama, Haruhiko Sugino, Andy Forbes, Robert D McQuade, Tetsuro Kikuch. Aripiprazole attenuates established behavioral sensitization induced by methamphetamine. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 6. 2010-11-02. PMID:20561555. |
in contrast, sulpiride, a dopamine d2 receptor specific antagonist, and risperidone, a serotonin 5-ht2 and dopamine d2 receptor antagonist, did not show effects similar to aripiprazole. |
2010-11-02 |
2023-08-12 |
mouse |
| Noriaki Hidaka, Katsuya Suemaru, Hiroaki Arak. Serotonin-dopamine antagonism ameliorates impairments of spontaneous alternation and locomotor hyperactivity induced by repeated electroconvulsive seizures in rats. Epilepsy research. vol 90. issue 3. 2010-11-02. PMID:20605414. |
the 5-ht(2) and d(2) receptor antagonist risperidone significantly ameliorated both behavioral impairments. |
2010-11-02 |
2023-08-12 |
rat |
| Tao Sun, Wei He, Gang Hu, Ming L. Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats. Pharmacology, biochemistry, and behavior. vol 95. issue 3. 2010-11-01. PMID:20167232. |
in this study, we examined the potential anxiolytic-like effects of risperidone and olanzapine, and compared them with haloperidol, chlordiazepoxide (a prototype of sedative-anxiolytic drug) or citalopram (a selective serotonin reuptake inhibitor). |
2010-11-01 |
2023-08-12 |
rat |
| Yong Kee Choi, Taylor Moran-Gates, Matthew P Gardner, Frank I Taraz. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 3. 2010-08-31. PMID:19875272. |
levels of 5-ht(1a) and 5-ht(2a) receptors in forebrain regions of juvenile rats were quantified after 3 weeks of treatment with three different doses of risperidone (0.3, 1.0 and 3.0mg/kg). |
2010-08-31 |
2023-08-12 |
rat |
| Yong Kee Choi, Taylor Moran-Gates, Matthew P Gardner, Frank I Taraz. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 3. 2010-08-31. PMID:19875272. |
findings were compared to previously reported changes in 5-ht receptors after risperidone treatment (3.0mg/kg) in adult rat brain. |
2010-08-31 |
2023-08-12 |
rat |
| Yong Kee Choi, Taylor Moran-Gates, Matthew P Gardner, Frank I Taraz. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 3. 2010-08-31. PMID:19875272. |
the three doses of risperidone selectively and dose-dependently increased levels of 5-ht(1a) receptors in medial-prefrontal and dorsolateral-frontal cortices of juvenile animals. |
2010-08-31 |
2023-08-12 |
rat |
| Yong Kee Choi, Taylor Moran-Gates, Matthew P Gardner, Frank I Taraz. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 3. 2010-08-31. PMID:19875272. |
the higher doses (1.0 and 3.0mg/kg) of risperidone also increased 5-ht(1a) receptor binding in hippocampal ca(1) region of juvenile but not adult rats. |
2010-08-31 |
2023-08-12 |
rat |
| Yong Kee Choi, Taylor Moran-Gates, Matthew P Gardner, Frank I Taraz. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 3. 2010-08-31. PMID:19875272. |
in contrast, the three doses of risperidone significantly reduced 5-ht(2a) labeling in medial-prefrontal and dorsolateral-frontal cortices in juvenile as well as in adult animals in an equipotent fashion. |
2010-08-31 |
2023-08-12 |
rat |
| Yong Kee Choi, Taylor Moran-Gates, Matthew P Gardner, Frank I Taraz. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 3. 2010-08-31. PMID:19875272. |
5-ht(1a) and 5-ht(2a) receptors in other forebrain regions were not altered by repeated risperidone treatment. |
2010-08-31 |
2023-08-12 |
rat |
| Yong Kee Choi, Taylor Moran-Gates, Matthew P Gardner, Frank I Taraz. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 3. 2010-08-31. PMID:19875272. |
these findings indicate that there are differential effects of risperidone on 5-ht(1a) and 5-ht(2a) receptors in juvenile animals, and that the 5-ht system in developing animals is more sensitive than adults to the long-term effects of risperidone. |
2010-08-31 |
2023-08-12 |
rat |
| Trisha A Jenkins, Jennifer J Elliott, Tara C Ardis, Marie Cahir, Gavin P Reynolds, Robert Bell, Stephen J Coope. Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone. Behavioural brain research. vol 208. issue 2. 2010-05-25. PMID:20043957. |
these data show that chronic lowering of central serotonin is associated with impaired cognitive performance, and that this can be reversed by the atypical antipsychotic, risperidone. |
2010-05-25 |
2023-08-12 |
rat |
| Karuppiah Kanagarajadurai, Manoharan Malini, Aditi Bhattacharya, Mitradas M Panicker, Ramanathan Sowdhamin. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding. Molecular bioSystems. vol 5. issue 12. 2010-05-12. PMID:19763327. |
further, starting from the model structure of human 5-ht(2a) receptor, docking studies were attempted to envisage how it might interact with eight of its ligands (such as serotonin, dopamine, doi, lsd, haloperidol, ketanserin, risperidone and clozapine). |
2010-05-12 |
2023-08-12 |
human |
| Chadi A Calarge, Bridget Zimmerman, Diqiong Xie, Samuel Kuperman, Janet A Schlecht. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. The Journal of clinical psychiatry. vol 71. issue 3. 2010-04-08. PMID:20331935. |
a cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. |
2010-04-08 |
2023-08-12 |
Not clear |
| Evrim Aktepe, Evrim Ozkorumak, Sema Tanriöver-Kandi. Pregnancy and delivery complications and treatment approach in attention deficit hyperactivity disorder. The Turkish journal of pediatrics. vol 51. issue 5. 2010-02-26. PMID:20112604. |
the other drugs used were risperidone (29.4%), selective serotonin reuptake inhibitors (16.4%) and imipramine (4.6%). |
2010-02-26 |
2023-08-12 |
Not clear |
| Alexandre Y Dombrovski, Benoit H Mulsant, Robert E Ferrell, Francis E Lotrich, Jules I Rosen, Meredith Wallace, Patricia R Houck, Sati Mazumdar, Bruce G Polloc. Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms. International clinical psychopharmacology. vol 25. issue 1. 2010-02-19. PMID:19996755. |
serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms. |
2010-02-19 |
2023-08-12 |
human |
| Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Tak Youn, Su-Jin Yang, Michael Y Hwang, Jin-Sang Yoo. The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia. Clinical neuropharmacology. vol 32. issue 4. 2009-10-08. PMID:19644229. |
we report the development of de novo obsession induced by sequential treatment with risperidone, aripiprazole, and ziprasidone, which have an antagonist effect on serotonin 5-ht(2a) receptors in a patient with schizophrenia. |
2009-10-08 |
2023-08-12 |
Not clear |
| Giuliana Salomoni, Massimiliano Grassi, Paola Mosini, Patrizia Riva, Paolo Cavedini, Laura Bellod. Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response. Journal of clinical psychopharmacology. vol 29. issue 4. 2009-09-17. PMID:19593173. |
we studied 130 subjects with ocd who underwent pharmacologic (with selective serotonin reuptake inhibitors alone or with selective serotonin reuptake inhibitors and risperidone at low dosage) and/or behavioral therapy (using exposure and response prevention techniques). |
2009-09-17 |
2023-08-12 |
human |